Schedule 13D ownership disclosure

20/20 BIOLABS INC

Common Stock, par value $0.01 · CUSIP: 90138K101

Event date: 2026-03-03

Filing-level shares
1,833,750.00
Percent of class
16.8%
  • Jonathan M CohenReported CIK 0002111543

    Shares: 1,833,750.00 · Class: 16.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-025764
Form type
SCHEDULE 13D
Filer
20/20 Biolabs, Inc.
CIK
CIK 1139685
Filed
Mar 10, 2026
Reporting period
Mar 03, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub